Therapeutics

Latest News

Vial partners with RecensMedical in phase 3 clinical trial
Vial partners with RecensMedical in phase 3 clinical trial

January 27th 2023

Vial will be supporting RecensMedical with the phase 3 clinical trial for its Ocu-Cool system.

New therapies suggest potential alternatives to retinal biologics
New therapies suggest potential alternatives to retinal biologics

January 27th 2023

 Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results
Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results

January 26th 2023

Thyroid eye disease candidate proves promising in phase 1/2 trial
Thyroid eye disease candidate proves promising in phase 1/2 trial

January 13th 2023

EyeCon 2022: Emerging therapies in geographic atrophy
EyeCon 2022: Emerging therapies in geographic atrophy

December 17th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.